Tech Company Financing Transactions
Proteostasis Therapeutics Funding Round
On 12/31/2010, Proteostasis Therapeutics received $23 million in funding from F-Prime Capital, HealthCare Ventures and private investors.
Transaction Overview
Company Name
Announced On
12/31/2010
Transaction Type
Venture Equity
Amount
$23,000,000
Round
Undisclosed
Investors
F-Prime Capital (Stephen Knight)
HealthCare Ventures (Christopher Mirabelli)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
80 Guest St. 5th Floor
Boston, MA 02135
USA
Boston, MA 02135
USA
Phone
Website
Email Address
Overview
Proteostasis Therapeutics (NASDAQ: PTI) is discovering and developing novel small molecule therapeutics designed to control the body's Proteostasis Network, which maintains the body's natural protein homeostasis to protect us from numerous diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Meenu Chhabra
Chief Medical Officer
Po-Shun Lee
Chief Operating Officer
Marija Zecevic
Chief Scientific Officer
Ben Munoz
VP - Bus. Development
Geoffrey Gilmartin
VP - Operations
Sheila Wilson
Browse more venture capital transactions:
Prev: 12/31/2010: Anterios venture capital transaction
Next: 12/31/2010: Typekit venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs